首页> 外国专利> Production of lymphoid tissue effector cells reactive against cancer cells by means of MER, and use thereof in cancer therapy

Production of lymphoid tissue effector cells reactive against cancer cells by means of MER, and use thereof in cancer therapy

机译:通过MER产生对癌细胞有反应性的淋巴组织效应细胞及其在癌症治疗中的用途

摘要

The addition of small amounts of MER to an in vitro culture of animal or human lymphocytes together with cancer cells will greatly potentiate the process by which the lymphocytes become actively cytotoxic to the specific type of cancer cells when injected in vivo. In some cases MER causes sensitization of the lymphocytes even when there is none without the MER. MER cultured in vitro with lymphocytes without specific cancer cells in the culture will cause non-specific cytotoxic sensitization of the lymphocytes. The sensitized cytotoxic reactive cells may be stored cryogenically for use in human cancer therapy.
机译:向动物或人淋巴细胞与癌细胞的体外培养物中添加少量MER,将大大增强淋巴细胞在体内注射时对特定类型癌细胞产生积极细胞毒性的过程。在某些情况下,即使没有MER,MER也会引起淋巴细胞致敏。用在培养物中没有特定癌细胞的淋巴细胞体外培养的MER将导致淋巴细胞的非特异性细胞毒性致敏作用。可将致敏的细胞毒性反应性细胞低温保存以用于人类癌症治疗。

著录项

  • 公开/公告号US4772469A

    专利类型

  • 公开/公告日1988-09-20

    原文格式PDF

  • 申请/专利权人 KEDAR;ELI;WEISS;DAVID W.;

    申请/专利号US19770844488

  • 发明设计人 ELI KEDAR;DAVID W. WEISS;

    申请日1977-10-21

  • 分类号A61K35/78;

  • 国家 US

  • 入库时间 2022-08-22 06:48:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号